Does BLINATUMOMAB Cause Mobility decreased? 12 Reports in FDA Database

Q: Does BLINATUMOMAB cause Mobility decreased?

12 reports of Mobility decreased have been filed with the FDA for BLINATUMOMAB, representing 0.1% of all BLINATUMOMAB adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Mobility decreased have been filed in association with BLINATUMOMAB (BLINCYTO). This represents 0.1% of all adverse event reports for BLINATUMOMAB.

Reports of Mobility decreased with BLINATUMOMAB

0.1%

of all BLINATUMOMAB reports

Deaths

Hospitalizations

How Dangerous Is Mobility decreased From BLINATUMOMAB?

Of the 12 reports, 9 (75.0%) required hospitalization, and 1 (8.3%) were considered life-threatening.

Is Mobility decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BLINATUMOMAB. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does BLINATUMOMAB Cause?

Pyrexia (1,064) Acute lymphocytic leukaemia recurrent (977) Cytokine release syndrome (952) Off label use (590) Death (588) Neurotoxicity (530) Drug ineffective (345) Headache (335) Neutropenia (265) Febrile neutropenia (262)

What Other Drugs Cause Mobility decreased?

ADALIMUMAB (8,829) ETANERCEPT (8,321) METHOTREXATE (5,936) ABATACEPT (4,519) TOCILIZUMAB (4,403) LEFLUNOMIDE (4,354) HYDROXYCHLOROQUINE (4,105) RITUXIMAB (4,067) INFLIXIMAB (3,784) TOFACITINIB (3,734)

Which BLINATUMOMAB Alternatives Have Lower Mobility decreased Risk?

BLINATUMOMAB vs BLONANSERIN BLINATUMOMAB vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 BLINATUMOMAB vs BOCEPREVIR BLINATUMOMAB vs BOCOCIZUMAB BLINATUMOMAB vs BONIVA

BLINATUMOMAB Full Profile All Mobility decreased Reports All Drugs Causing Mobility decreased BLINATUMOMAB Demographics